Enanta Pharmaceuticals Inc (ENTA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

500 ARSENAL STREET WATERTOWN, MA 02472

Enanta Pharmaceuticals, Inc., a biotechnology company, engages in the development of small molecule drugs for the infectious disease areas. Its product candidates include ABT-450, an inhibitor of NS3 protease that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV) infection; EDP-239, an NS5A Inhibitor for HCV infection; EDP-546, a Cyclophilin inhibitor, which is in preclinical studies for HCV infection treatment; and Nucleotide Polymerase inhibitor for HCV infection.

Data based on most recent fiscal year report
Market Cap1.567 Billion Shares Outstanding19.15 Million Avg Volume313.658 Thousand
1-Yr BETA vs S&P TR Current Ratio11.34 Quick Ratio11.34
View SEC Filings from ENTA instead.

View recent insider trading info

Funds Holding ENTA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ENTA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

10 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

25.9 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GOLUMBESKI GEORGE

0 2020-01-03 3

CARTER BRUCE L A

2,000 2020-01-03 3

OR YAT SUN SR. VP & CSO

  • Officer
303,592 2019-12-16 4

MELLETT PAUL J TREASURER AND CFO

  • Officer
40,054 2019-12-16 4

LULY JAY R. PRESIDENT AND CEO

  • Officer
  • Director
642,416 2019-12-16 4

GARDINER NATHANIEL S. SR. VP & GENERAL COUNSEL

  • Officer
39,303 2019-12-16 8

ADDA NATHALIE SR. VP & CHIEF MEDICAL OFFICER

  • Officer
13,313 2019-12-16 3

PETERSON KRISTINE

0 2019-06-25 1

BUCKLEY STEPHEN JR.

  • Director
0 2019-02-28 1

VANCE TERRY

  • Director
0 2019-02-28 1

RUSSELL LESLEY

  • Director
0 2019-02-28 1

OCAIN TIM SENIOR VICE PRESIDENT

  • Officer
17,547 2019-02-12 1

AFTING ERNST-GUENTER

  • Director
0 2016-02-11 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MELLETT PAUL J - Officer TREASURER AND CFO

2020-01-02 S 9,279 $60.82 d 40,775 40,054.00 direct yes

MELLETT PAUL J - Officer TREASURER AND CFO

2020-01-02 S 721 $61.66 d 40,054 40,054.00 direct yes

GARDINER NATHANIEL S. - Officer SR. VP & GENERAL COUNSEL

2019-12-16 M 5,250 a 24,989 39,303.00 direct

LULY JAY R. - Director - Officer PRESIDENT AND CEO

2019-12-16 M 7,500 d 7,500 642,416.00 direct

OR YAT SUN - Officer SR. VP & CSO

2019-12-16 M 5,250 d 5,250 303,592.00 direct

ADDA NATHALIE - Officer SR. VP & CHIEF MEDICAL OFFICER

2019-12-16 M 5,250 d 5,250 13,313.00 direct

GARDINER NATHANIEL S. - Officer SR. VP & GENERAL COUNSEL

2019-12-16 M 5,250 d 5,250 39,303.00 direct

MELLETT PAUL J - Officer TREASURER AND CFO

2019-12-16 M 2,625 d 2,625 40,054.00 direct

MELLETT PAUL J - Officer TREASURER AND CFO

2019-12-16 F 1,165 $63.88 d 50,054 40,054.00 direct

LULY JAY R. - Director - Officer PRESIDENT AND CEO

2019-12-16 F 3,330 $63.88 d 642,416 642,416.00 direct

OR YAT SUN - Officer SR. VP & CSO

2019-12-16 F 2,331 $63.88 d 303,592 303,592.00 direct

ADDA NATHALIE - Officer SR. VP & CHIEF MEDICAL OFFICER

2019-12-16 F 2,331 $63.88 d 13,313 13,313.00 direct

GARDINER NATHANIEL S. - Officer SR. VP & GENERAL COUNSEL

2019-12-16 F 2,331 $63.88 d 22,658 39,303.00 direct

MELLETT PAUL J - Officer TREASURER AND CFO

2019-12-16 M 2,625 a 51,219 40,054.00 direct

LULY JAY R. - Director - Officer PRESIDENT AND CEO

2019-12-16 M 7,500 a 645,746 642,416.00 direct

OR YAT SUN - Officer SR. VP & CSO

2019-12-16 M 5,250 a 305,923 303,592.00 direct

ADDA NATHALIE - Officer SR. VP & CHIEF MEDICAL OFFICER

2019-12-16 M 5,250 a 15,644 13,313.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments